Dr Kevin Herman, MD | |
718 Teaneck Rd, Teaneck, NJ 07666-4245 | |
(201) 227-6210 | |
(201) 643-3077 |
Full Name | Dr Kevin Herman |
---|---|
Gender | Male |
Speciality | Interventional Radiology |
Experience | 21 Years |
Location | 718 Teaneck Rd, Teaneck, New Jersey |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1619107703 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Holy Name Medical Center | Teaneck, NJ | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Nj Endovascular And Amputation Prevention, Llc | 2961764493 | 4 |
Peace Health Partners, Pc | 6709776222 | 12 |
News Archive
In a New York City metro-area first, a 93-year-old Bronx man underwent implantation of a new stent graft at NewYork-Presbyterian Hospital, the only center on the Eastern Seaboard with access to this investigational device. The new stent graft was implanted under an FDA-approved clinical trial protocol.
MEDIAN Technologies, a leading medical imaging software developer and service provider for oncology clinical trials, announced today its participation in the 2012 ASCO annual conference, to be held next June 1-5, in Chicago, IL, USA.
A University of Sydney professor who developed a system to combat bioterrorism has received a major award from the US military.
Aerospace giant Boeing tested two kinds of ionization technologies — like those widely adopted in schools hoping to combat covid — to determine how well each killed germs on surfaces and decided that neither was effective enough to install on its commercial planes.
Genetic testing for mutations beyond those currently recommended in medical guidelines may aid the identification of more couples at risk of having a child with cystic fibrosis, according to a study presented today at the 2015 American Society of Human Genetics Annual Meeting, which runs through October 10 in Baltimore, Maryland.
› Verified 9 days ago
Entity Name | Peace Health Partners, Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1265463954 PECOS PAC ID: 6709776222 Enrollment ID: O20040318000511 |
News Archive
In a New York City metro-area first, a 93-year-old Bronx man underwent implantation of a new stent graft at NewYork-Presbyterian Hospital, the only center on the Eastern Seaboard with access to this investigational device. The new stent graft was implanted under an FDA-approved clinical trial protocol.
MEDIAN Technologies, a leading medical imaging software developer and service provider for oncology clinical trials, announced today its participation in the 2012 ASCO annual conference, to be held next June 1-5, in Chicago, IL, USA.
A University of Sydney professor who developed a system to combat bioterrorism has received a major award from the US military.
Aerospace giant Boeing tested two kinds of ionization technologies — like those widely adopted in schools hoping to combat covid — to determine how well each killed germs on surfaces and decided that neither was effective enough to install on its commercial planes.
Genetic testing for mutations beyond those currently recommended in medical guidelines may aid the identification of more couples at risk of having a child with cystic fibrosis, according to a study presented today at the 2015 American Society of Human Genetics Annual Meeting, which runs through October 10 in Baltimore, Maryland.
› Verified 9 days ago
Entity Name | Garden State Cardiovascular Specialists Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1225059660 PECOS PAC ID: 8527053511 Enrollment ID: O20040419000924 |
News Archive
In a New York City metro-area first, a 93-year-old Bronx man underwent implantation of a new stent graft at NewYork-Presbyterian Hospital, the only center on the Eastern Seaboard with access to this investigational device. The new stent graft was implanted under an FDA-approved clinical trial protocol.
MEDIAN Technologies, a leading medical imaging software developer and service provider for oncology clinical trials, announced today its participation in the 2012 ASCO annual conference, to be held next June 1-5, in Chicago, IL, USA.
A University of Sydney professor who developed a system to combat bioterrorism has received a major award from the US military.
Aerospace giant Boeing tested two kinds of ionization technologies — like those widely adopted in schools hoping to combat covid — to determine how well each killed germs on surfaces and decided that neither was effective enough to install on its commercial planes.
Genetic testing for mutations beyond those currently recommended in medical guidelines may aid the identification of more couples at risk of having a child with cystic fibrosis, according to a study presented today at the 2015 American Society of Human Genetics Annual Meeting, which runs through October 10 in Baltimore, Maryland.
› Verified 9 days ago
Entity Name | Senior Healthcare Outreach Program |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1588707954 PECOS PAC ID: 5890893713 Enrollment ID: O20070531000042 |
News Archive
In a New York City metro-area first, a 93-year-old Bronx man underwent implantation of a new stent graft at NewYork-Presbyterian Hospital, the only center on the Eastern Seaboard with access to this investigational device. The new stent graft was implanted under an FDA-approved clinical trial protocol.
MEDIAN Technologies, a leading medical imaging software developer and service provider for oncology clinical trials, announced today its participation in the 2012 ASCO annual conference, to be held next June 1-5, in Chicago, IL, USA.
A University of Sydney professor who developed a system to combat bioterrorism has received a major award from the US military.
Aerospace giant Boeing tested two kinds of ionization technologies — like those widely adopted in schools hoping to combat covid — to determine how well each killed germs on surfaces and decided that neither was effective enough to install on its commercial planes.
Genetic testing for mutations beyond those currently recommended in medical guidelines may aid the identification of more couples at risk of having a child with cystic fibrosis, according to a study presented today at the 2015 American Society of Human Genetics Annual Meeting, which runs through October 10 in Baltimore, Maryland.
› Verified 9 days ago
Entity Name | Prime Healthcare Services - St Mary's Passaic, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1730508250 PECOS PAC ID: 6305066911 Enrollment ID: O20141031000263 |
News Archive
In a New York City metro-area first, a 93-year-old Bronx man underwent implantation of a new stent graft at NewYork-Presbyterian Hospital, the only center on the Eastern Seaboard with access to this investigational device. The new stent graft was implanted under an FDA-approved clinical trial protocol.
MEDIAN Technologies, a leading medical imaging software developer and service provider for oncology clinical trials, announced today its participation in the 2012 ASCO annual conference, to be held next June 1-5, in Chicago, IL, USA.
A University of Sydney professor who developed a system to combat bioterrorism has received a major award from the US military.
Aerospace giant Boeing tested two kinds of ionization technologies — like those widely adopted in schools hoping to combat covid — to determine how well each killed germs on surfaces and decided that neither was effective enough to install on its commercial planes.
Genetic testing for mutations beyond those currently recommended in medical guidelines may aid the identification of more couples at risk of having a child with cystic fibrosis, according to a study presented today at the 2015 American Society of Human Genetics Annual Meeting, which runs through October 10 in Baltimore, Maryland.
› Verified 9 days ago
Entity Name | Central Avenue Professional Services, Pc |
---|---|
Entity Type | Part B Supplier - Hospital Department(s) |
Entity Identifiers | NPI Number: 1447649694 PECOS PAC ID: 7214258003 Enrollment ID: O20150604002544 |
News Archive
In a New York City metro-area first, a 93-year-old Bronx man underwent implantation of a new stent graft at NewYork-Presbyterian Hospital, the only center on the Eastern Seaboard with access to this investigational device. The new stent graft was implanted under an FDA-approved clinical trial protocol.
MEDIAN Technologies, a leading medical imaging software developer and service provider for oncology clinical trials, announced today its participation in the 2012 ASCO annual conference, to be held next June 1-5, in Chicago, IL, USA.
A University of Sydney professor who developed a system to combat bioterrorism has received a major award from the US military.
Aerospace giant Boeing tested two kinds of ionization technologies — like those widely adopted in schools hoping to combat covid — to determine how well each killed germs on surfaces and decided that neither was effective enough to install on its commercial planes.
Genetic testing for mutations beyond those currently recommended in medical guidelines may aid the identification of more couples at risk of having a child with cystic fibrosis, according to a study presented today at the 2015 American Society of Human Genetics Annual Meeting, which runs through October 10 in Baltimore, Maryland.
› Verified 9 days ago
Entity Name | Smgh Physician Practice Management Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1033578075 PECOS PAC ID: 6406141480 Enrollment ID: O20160830001733 |
News Archive
In a New York City metro-area first, a 93-year-old Bronx man underwent implantation of a new stent graft at NewYork-Presbyterian Hospital, the only center on the Eastern Seaboard with access to this investigational device. The new stent graft was implanted under an FDA-approved clinical trial protocol.
MEDIAN Technologies, a leading medical imaging software developer and service provider for oncology clinical trials, announced today its participation in the 2012 ASCO annual conference, to be held next June 1-5, in Chicago, IL, USA.
A University of Sydney professor who developed a system to combat bioterrorism has received a major award from the US military.
Aerospace giant Boeing tested two kinds of ionization technologies — like those widely adopted in schools hoping to combat covid — to determine how well each killed germs on surfaces and decided that neither was effective enough to install on its commercial planes.
Genetic testing for mutations beyond those currently recommended in medical guidelines may aid the identification of more couples at risk of having a child with cystic fibrosis, according to a study presented today at the 2015 American Society of Human Genetics Annual Meeting, which runs through October 10 in Baltimore, Maryland.
› Verified 9 days ago
Entity Name | Nj Endovascular & Amputation Prevention, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1912412446 PECOS PAC ID: 2961764493 Enrollment ID: O20180322000036 |
News Archive
In a New York City metro-area first, a 93-year-old Bronx man underwent implantation of a new stent graft at NewYork-Presbyterian Hospital, the only center on the Eastern Seaboard with access to this investigational device. The new stent graft was implanted under an FDA-approved clinical trial protocol.
MEDIAN Technologies, a leading medical imaging software developer and service provider for oncology clinical trials, announced today its participation in the 2012 ASCO annual conference, to be held next June 1-5, in Chicago, IL, USA.
A University of Sydney professor who developed a system to combat bioterrorism has received a major award from the US military.
Aerospace giant Boeing tested two kinds of ionization technologies — like those widely adopted in schools hoping to combat covid — to determine how well each killed germs on surfaces and decided that neither was effective enough to install on its commercial planes.
Genetic testing for mutations beyond those currently recommended in medical guidelines may aid the identification of more couples at risk of having a child with cystic fibrosis, according to a study presented today at the 2015 American Society of Human Genetics Annual Meeting, which runs through October 10 in Baltimore, Maryland.
› Verified 9 days ago
Entity Name | Hudson Premier Medical Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1548809221 PECOS PAC ID: 4688095367 Enrollment ID: O20200604002360 |
News Archive
In a New York City metro-area first, a 93-year-old Bronx man underwent implantation of a new stent graft at NewYork-Presbyterian Hospital, the only center on the Eastern Seaboard with access to this investigational device. The new stent graft was implanted under an FDA-approved clinical trial protocol.
MEDIAN Technologies, a leading medical imaging software developer and service provider for oncology clinical trials, announced today its participation in the 2012 ASCO annual conference, to be held next June 1-5, in Chicago, IL, USA.
A University of Sydney professor who developed a system to combat bioterrorism has received a major award from the US military.
Aerospace giant Boeing tested two kinds of ionization technologies — like those widely adopted in schools hoping to combat covid — to determine how well each killed germs on surfaces and decided that neither was effective enough to install on its commercial planes.
Genetic testing for mutations beyond those currently recommended in medical guidelines may aid the identification of more couples at risk of having a child with cystic fibrosis, according to a study presented today at the 2015 American Society of Human Genetics Annual Meeting, which runs through October 10 in Baltimore, Maryland.
› Verified 9 days ago
Entity Name | Hudson Md Group |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1497301998 PECOS PAC ID: 6103240478 Enrollment ID: O20200720001687 |
News Archive
In a New York City metro-area first, a 93-year-old Bronx man underwent implantation of a new stent graft at NewYork-Presbyterian Hospital, the only center on the Eastern Seaboard with access to this investigational device. The new stent graft was implanted under an FDA-approved clinical trial protocol.
MEDIAN Technologies, a leading medical imaging software developer and service provider for oncology clinical trials, announced today its participation in the 2012 ASCO annual conference, to be held next June 1-5, in Chicago, IL, USA.
A University of Sydney professor who developed a system to combat bioterrorism has received a major award from the US military.
Aerospace giant Boeing tested two kinds of ionization technologies — like those widely adopted in schools hoping to combat covid — to determine how well each killed germs on surfaces and decided that neither was effective enough to install on its commercial planes.
Genetic testing for mutations beyond those currently recommended in medical guidelines may aid the identification of more couples at risk of having a child with cystic fibrosis, according to a study presented today at the 2015 American Society of Human Genetics Annual Meeting, which runs through October 10 in Baltimore, Maryland.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Kevin Herman, MD Po Box 305, Briarcliff Manor, NY 10510-0405 Ph: (201) 227-6210 | Dr Kevin Herman, MD 718 Teaneck Rd, Teaneck, NJ 07666-4245 Ph: (201) 227-6210 |
News Archive
In a New York City metro-area first, a 93-year-old Bronx man underwent implantation of a new stent graft at NewYork-Presbyterian Hospital, the only center on the Eastern Seaboard with access to this investigational device. The new stent graft was implanted under an FDA-approved clinical trial protocol.
MEDIAN Technologies, a leading medical imaging software developer and service provider for oncology clinical trials, announced today its participation in the 2012 ASCO annual conference, to be held next June 1-5, in Chicago, IL, USA.
A University of Sydney professor who developed a system to combat bioterrorism has received a major award from the US military.
Aerospace giant Boeing tested two kinds of ionization technologies — like those widely adopted in schools hoping to combat covid — to determine how well each killed germs on surfaces and decided that neither was effective enough to install on its commercial planes.
Genetic testing for mutations beyond those currently recommended in medical guidelines may aid the identification of more couples at risk of having a child with cystic fibrosis, according to a study presented today at the 2015 American Society of Human Genetics Annual Meeting, which runs through October 10 in Baltimore, Maryland.
› Verified 9 days ago
Mr. Howard Lawrence Kirzner, MD Radiology Medicare: Medicare Enrolled Practice Location: 699 Teaneck Road, Teaneck, NJ 07666 Phone: 201-836-2500 Fax: 201-836-0083 | |
Charles P Vialotti, MD Radiology Medicare: Medicare Enrolled Practice Location: 718 Teaneck Rd, Teaneck, NJ 07666 Phone: 201-541-5900 Fax: 201-541-0305 | |
Mrs. Adrienne Masin Greenblatt, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 699 Teaneck Road, Teaneck, NJ 07666 Phone: 201-836-2500 Fax: 201-836-7921 | |
Dr. Joshua D. Gross, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 718 Teaneck Rd, Teaneck, NJ 07666 Phone: 201-833-7100 Fax: 201-833-7248 | |
John Rundback, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 718 Teaneck Rd, Teaneck, NJ 07666 Phone: 201-227-6210 Fax: 201-643-3077 | |
Daniel Brian Lerer, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 788 Winthrop Rd, Teaneck, NJ 07666 Phone: 201-281-0316 Fax: 201-836-3194 | |
Howard Berman, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: Holy Name Hospital Department Of Radiology, 718 Teaneck Rd, Teaneck, NJ 07666 Phone: 201-833-3445 |